[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,268,383
  • Shares Outstanding, K 61,903
  • Annual Sales, $ 0 K
  • Annual Income, $ -255,840 K
  • EBIT $ -305 M
  • EBITDA $ -311 M
  • 60-Month Beta 0.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.56

Options Overview Details

View History
  • Implied Volatility 9.97% (-4.57%)
  • Historical Volatility 117.80%
  • IV Percentile 3%
  • IV Rank 3.20%
  • IV High 119.84% on 03/18/26
  • IV Low 6.34% on 06/23/26
  • Expected Move (DTE 7) 1.20 (0.90%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 209
  • Volume Avg (30-Day) 1,075
  • Put/Call OI Ratio 2.67
  • Today's Open Interest 21,069
  • Open Int (30-Day) 15,324
  • Expected Range 132.45 to 134.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.10
  • Number of Estimates 3
  • High Estimate $-1.05
  • Low Estimate $-1.13
  • Prior Year $-1.13
  • Growth Rate Est. (year over year) +2.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.71 +61.58%
on 06/11/26
133.87 -0.16%
on 07/07/26
+50.93 (+61.57%)
since 06/10/26
3-Month
75.00 +78.20%
on 05/21/26
133.87 -0.16%
on 07/07/26
+47.38 (+54.92%)
since 04/10/26
52-Week
34.34 +289.20%
on 08/08/25
133.87 -0.16%
on 07/07/26
+95.08 (+246.51%)
since 07/10/25

Most Recent Stories

More News
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years

While one continues reinvesting for growth, the other has rewarded shareholders for 54 years in a row.

APGE : 133.65 (+0.06%)
LLY : 1,188.58 (-2.33%)
ABBV : 248.08 (-0.73%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPRO

NEW YORK , July 6, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

LPRO : 3.12 (-0.32%)
APGE : 133.65 (+0.06%)
TMHC : 71.85 (+0.07%)
AVB : 191.84 (+1.26%)
Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

APGE : 133.65 (+0.06%)
CBAN : 20.11 (+0.45%)
INVE : 2.93 (+6.93%)
FSRL : 18.4000 (unch)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS

NEW YORK , July 2, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

APGE : 133.65 (+0.06%)
BOLD : 2.41 (-3.98%)
GBCS : 5.2100 (-0.76%)
ACA : 145.00 (+0.02%)
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

REFI : 10.82 (+1.22%)
TECH : 71.30 (+0.21%)
APGE : 133.65 (+0.06%)
BOLD : 2.41 (-3.98%)
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Apogee Therapeutics...

APGE : 133.65 (+0.06%)
ABBV : 248.08 (-0.73%)
AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.

Apogee’s rally may be over, but AbbVie’s upside from the deal could just be getting started.

APGE : 133.65 (+0.06%)
$SPX : 7,575.39 (+0.42%)
ABBV : 248.08 (-0.73%)
The $11 Billion Reason Abbvie Stock Is Up Today

AbbVie stock rallied today on the $10.9 billion acquisition of Apogee Therapeutics. Here’s how you should play ABBV shares at current levels.

APGE : 133.65 (+0.06%)
JNJ : 256.98 (-0.82%)
LLY : 1,188.58 (-2.33%)
ABBV : 248.08 (-0.73%)
REGN : 664.52 (-0.51%)
SNY : 43.50 (-0.91%)
US stocks drift after oil prices ease and Big Tech stocks fall

U.S. stocks drifted through a mixed day of trading after oil prices eased and falling Big Tech stocks weighed on Wall Street

APGE : 133.65 (+0.06%)
AVGO : 399.97 (-0.28%)
$SPX : 7,575.39 (+0.42%)
$DOWI : 52,637.01 (+0.29%)
CME : 240.27 (+0.23%)
ABBV : 248.08 (-0.73%)
$IUXX : 29,825.11 (+0.33%)
AMZN : 245.34 (-0.69%)
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.19%. September...

GOOGL : 357.18 (-0.48%)
AAPL : 315.32 (-0.28%)
SNDK : 1,915.92 (+3.10%)
ADI : 395.65 (+0.51%)
TSLA : 407.76 (+0.30%)
STX : 910.34 (+2.28%)
AMD : 557.89 (+2.04%)
DFTX : 47.07 (-2.85%)
SPY : 754.95 (+0.43%)
META : 669.21 (+5.97%)
NOC : 539.63 (+1.39%)
FRVO : 27.13 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 134.19
2nd Resistance Point 133.97
1st Resistance Point 133.81
Last Price 133.65
1st Support Level 133.43
2nd Support Level 133.20
3rd Support Level 133.04

See More

52-Week High 133.87
Last Price 133.65
Fibonacci 61.8% 95.85
Fibonacci 50% 84.10
Fibonacci 38.2% 72.36
52-Week Low 34.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.